From GlobeNewswire: 2025-03-21 09:00:00

United-Guardian, Inc. (NASDAQ:UG) reported a 12% increase in net sales from $10,885,154 in 2023 to $12,181,971 in 2024. Net income also rose to $3,250,875 in 2024 compared to $2,581,370 in 2023 ($0.71 per share). Sales increased due to higher demand for cosmetic and medical products, with pharmaceutical sales decreasing by 5% in 2024 due to supply disruptions of Renacidin.

President Donna Vigilante stated that cosmetic ingredient sales increased by 32% and medical lubricant sales by 16% in 2024. The rise was driven by increased purchase orders from distributors, particularly in China. Pharmaceutical sales declined by 5% due to supply disruptions of Renacidin, but sales are expected to return to previous levels in 2025.

United-Guardian is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The company’s financial results for 2024 show net sales of $12,181,971, operating income of $3,646,789, and net income of $3,250,875. The balance sheet data for 2024 includes total assets of $13,797,335 and total stockholders’ equity of $11,882,866.



Read more at GlobeNewswire:: United-Guardian Reports 2024 Financial Results